Literature DB >> 8740697

Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16).

A D Singh1, C M Croce, K K Wary, J A Shields, L A Donoso, C L Shields, K Huebner, M Ohta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8740697     DOI： 10.3109/13816819609057868

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN： 1381-6810            Impact factor:   1.803


× No keyword cloud information.
  6 in total

Review 1.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

2.  Germline BAP1 alterations in familial uveal melanoma.

Authors:  Karan Rai; Robert Pilarski; Getachew Boru; Muneeb Rehman; Ahmad H Saqr; James B Massengill; Arun Singh; Meghan J Marino; Frederick H Davidorf; Colleen M Cebulla; Mohamed H Abdel-Rahman
Journal:  Genes Chromosomes Cancer       Date:  2016-10-26       Impact factor: 5.006

Review 3.  Genetics of primary intraocular tumors.

Authors:  Nisha Nagarkatti-Gude; Yujuan Wang; Mohammad Javed Ali; Santosh G Honavar; Martine J Jager; Chi-Chao Chan
Journal:  Ocul Immunol Inflamm       Date:  2012-08       Impact factor: 3.070

4.  Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.

Authors:  N Soufir; B Bressac-de Paillerets; L Desjardins; C Lévy; J Bombled; I Gorin; P Schlienger; D Stoppa-Lyonnet
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

Review 5.  The genetics of uveal melanoma: current insights.

Authors:  Hildur Helgadottir; Veronica Höiom
Journal:  Appl Clin Genet       Date:  2016-09-06

Review 6.  Metastatic disease from uveal melanoma: treatment options and future prospects.

Authors:  Richard D Carvajal; Gary K Schwartz; Tongalp Tezel; Brian Marr; Jasmine H Francis; Paul D Nathan
Journal:  Br J Ophthalmol       Date:  2016-08-29       Impact factor: 4.638
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.